Cornerstone Investment Partners’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$276K Sell
2,877
-139
-5% -$14.3K 0.01% 204
2026
Q1
$329K Buy
+3,016
New +$287K 0.01% 117
2025
Q4
Sell
-2,321
Closed -$203K 244
2025
Q3
$203K Sell
2,321
-171
-7% -$15.3K 0.01% 161
2025
Q2
$207K Buy
2,492
+1
+0% +$84 0.01% 160
2025
Q1
$209K Sell
2,491
-220
-8% -$20.5K 0.01% 128
2024
Q4
$250K Buy
2,711
+2
+0.1% +$192 0.01% 139
2024
Q3
$252K Buy
2,709
+84
+3% +$7.28K 0.01% 134
2024
Q2
$216K Buy
+2,625
New +$193K 0.01% 155
2021
Q1
Sell
-5,223
Closed -$212K 288
2020
Q4
$212K Buy
+5,223
New +$187K 0.01% 156
2020
Q1
Sell
-5,898
Closed -$212K 201
2019
Q4
$212K Buy
+5,898
New +$204K 0.01% 147

Other funds holding LMAT

Cornerstone Investment Partners's LMAT Position: Q2 2026 in Review

Cornerstone Investment Partners reduced its LeMaitre Vascular (LMAT) stake by 4.6% in Q2 2026, selling an estimated $14.3K and leaving 2,877 shares worth $276K. The position accounts for 0.01% of the portfolio, ranked #204.

Cornerstone Investment Partners first reported a position in LMAT in Q4 2019 and has held it in 10 quarters since. The position peaked at $329K in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Cornerstone Investment Partners held 2,877 shares of LeMaitre Vascular worth $276K as of Q2 2026.
  • Cornerstone Investment Partners sold 139 LeMaitre Vascular shares in Q2 2026, an estimated $14.3K.
  • LeMaitre Vascular made up 0.01% of Cornerstone Investment Partners's portfolio in Q2 2026, its #204 holding.
  • Cornerstone Investment Partners first reported a position in LeMaitre Vascular in Q4 2019 and has held it in 10 quarters since.
  • Cornerstone Investment Partners's LeMaitre Vascular position peaked at $329K in Q1 2026.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Cornerstone Investment Partners's 13F filing for Q2 2026, filed 7 Aug 2026.